These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 24857605)

  • 1. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-applied curcumin for different diseases therapy.
    Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
    Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review.
    Hani U; Shivakumar HG
    Curr Drug Deliv; 2014; 11(6):792-804. PubMed ID: 25176028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short review on chemical properties, stability and nano-technological advances for curcumin delivery.
    Slika L; Patra D
    Expert Opin Drug Deliv; 2020 Jan; 17(1):61-75. PubMed ID: 31810374
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
    Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
    J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
    Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
    Mohanty C; Sahoo SK
    Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS®.
    Kim YH; Lee SJ; Lee SH; Hahn M
    Pharm Dev Technol; 2012; 17(6):677-86. PubMed ID: 23216046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
    Manju S; Sreenivasan K
    Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
    Kolter M; Wittmann M; Köll-Weber M; Süss R
    Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
    Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.